U2CDK133488
Cooperative Agreement
Overview
Grant Description
Learners to Leaders in Benign Urology, Benign Nephrology, and Non-Cancer Hematology - Project Abstract Program Overview
This is a single consolidated U2C/TL1 training program (the Learners to Leaders in Benign Urology, Benign Nephrology, and Non-Cancer Hematology [LAUNCH] program) that seeks to integrate, expand, and transform kidney, urologic, and hematologic (KUH) biomedical research training in Northern California.
Based at four institutions with outstanding research resources and training accomplishments—University of California San Francisco (UCSF), University of California Berkeley (UC Berkeley), University of California Davis (UC Davis), and Stanford University—we propose an innovative approach to train 22 (4 pre- and 18 post-doctoral) trainees annually across adult and pediatric KUH disciplines.
We will identify and recruit the most promising and diverse group of trainees to enable them to conduct KUH research and provide these LAUNCH program trainees with outstanding basic, translational, or clinical research training.
Our overall goal is to establish a unified training program that promotes interdisciplinary collaboration and training of the most promising junior investigators across our four institutions. Thus, we expect that the LAUNCH program will graduate scientists who are well-trained, able to compete successfully for research funding, and able to think creatively and collaboratively to generate novel and impactful science.
The LAUNCH program will be led by the U2C multi-PIs (Drs. Elaine Ku, Marshall Stoller, and Kathleen Sakamoto) as well as the TL1 multi-PIs (Drs. Chi-Yuan Hsu, Philip Beachy, and Mark Walters), each of whom possess complementary expertise in research and research training within the disciplines of nephrology, urology, and hematology.
The world-class training faculty whom we have included in our program were selected not only based on their own scientific and scholarly achievements but also their track record of mentorship and commitment to training.
The LAUNCH program is modeled after several highly-successful training programs at our institutions that have trained numerous exceptional scientists from a wide range of disciplines using a team science approach.
This is a single consolidated U2C/TL1 training program (the Learners to Leaders in Benign Urology, Benign Nephrology, and Non-Cancer Hematology [LAUNCH] program) that seeks to integrate, expand, and transform kidney, urologic, and hematologic (KUH) biomedical research training in Northern California.
Based at four institutions with outstanding research resources and training accomplishments—University of California San Francisco (UCSF), University of California Berkeley (UC Berkeley), University of California Davis (UC Davis), and Stanford University—we propose an innovative approach to train 22 (4 pre- and 18 post-doctoral) trainees annually across adult and pediatric KUH disciplines.
We will identify and recruit the most promising and diverse group of trainees to enable them to conduct KUH research and provide these LAUNCH program trainees with outstanding basic, translational, or clinical research training.
Our overall goal is to establish a unified training program that promotes interdisciplinary collaboration and training of the most promising junior investigators across our four institutions. Thus, we expect that the LAUNCH program will graduate scientists who are well-trained, able to compete successfully for research funding, and able to think creatively and collaboratively to generate novel and impactful science.
The LAUNCH program will be led by the U2C multi-PIs (Drs. Elaine Ku, Marshall Stoller, and Kathleen Sakamoto) as well as the TL1 multi-PIs (Drs. Chi-Yuan Hsu, Philip Beachy, and Mark Walters), each of whom possess complementary expertise in research and research training within the disciplines of nephrology, urology, and hematology.
The world-class training faculty whom we have included in our program were selected not only based on their own scientific and scholarly achievements but also their track record of mentorship and commitment to training.
The LAUNCH program is modeled after several highly-successful training programs at our institutions that have trained numerous exceptional scientists from a wide range of disciplines using a team science approach.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
San Francisco,
California
941432203
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 290% from $832,601 to $3,247,140.
San Francisco Regents Of The University Of California was awarded
LAUNCH Program: Transforming KUH Research Training
Cooperative Agreement U2CDK133488
worth $3,247,140
from the National Institute of Diabetes and Digestive and Kidney Diseases in September 2023 with work to be completed primarily in San Francisco California United States.
The grant
has a duration of 4 years 9 months and
was awarded through assistance program 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research.
The Cooperative Agreement was awarded through grant opportunity Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed).
Status
(Ongoing)
Last Modified 6/22/26
Period of Performance
9/1/23
Start Date
6/30/28
End Date
Funding Split
$3.2M
Federal Obligation
$0.0
Non-Federal Obligation
$3.2M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U2CDK133488
Transaction History
Modifications to U2CDK133488
Additional Detail
Award ID FAIN
U2CDK133488
SAI Number
U2CDK133488-1193965725
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NK00 NIH National Institute of Diabetes and Digestive and Kidney Diseases
Funding Office
75NK00 NIH National Institute of Diabetes and Digestive and Kidney Diseases
Awardee UEI
KMH5K9V7S518
Awardee CAGE
4B560
Performance District
CA-11
Senators
Dianne Feinstein
Alejandro Padilla
Alejandro Padilla
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Health and Human Services (075-0884) | Health research and training | Grants, subsidies, and contributions (41.0) | $832,601 | 100% |
Modified: 6/22/26